Abstract
. Following the nomenclatorial principle of mutant proteins in certain neuromuscular disorders such as dytrophinopathies, sarcoglycanopathies, dysferlinopathy and others, respective protein abnormalities being marked by reduction or absence of these largely transsarcolemmal proteins [3] , the term desminopathy has been coined for a distinct form of protein aggregate myopathy due to desmin mutations [4] . Actinopathy [14] . This assembly process is the structural basis for the formation of the three-dimensional desmin IF network in all mature muscle cells [15] .
A milestone in our current understanding of desmin function was the generation of desmin (-/-) mice by two independent laboratories [16, 17] [12] . In normal muscle, the extrasarcomeric cytoskeleton is composed of a network of various components, comprising the IF proteins desmin, synemin and syncoilin, the molecular chaperone ␣B-crystallin, and the multi-functional cytoskeletal linker plectin [12, 13, 18] [4] . 
Sub-sarcolemmal and cytoplasmic desmin-positive protein aggregates: the morphological hallmark of primary and secondary desminopathies
A broad spectrum of myopathological changes ranging from mild to severe degenerative muscle alterations has been described in genetically proven primary desminopathies [7, 20, 21] [7, 9, 20] [24] , an increasing number of patients harbouring desmin mutations have been described [4, 21] 6 , which encodes the C-terminal part of the 2B helix, has been described, which makes this exon a primary target for mutation analysis [4, 25] . [26] . [20, 21, 25, 27, 28] [21, 25, 27] , 
The spectrum of pathogenic desmin gene mutations

The human desmin protein (476 amino acids) is encoded by a single copy gene (nine exons) on chromosome 2q35. Since the first description of pathogenic desmin mutations
A number of recent studies provided important new insights in the molecular pathogenesis of primary desminopathies. The corroborative data derived from transient transfection studies indicate that the majority of desmin rod mutants are incapable of forming a de novo desmin IF network in human SW13 cells, which are completely devoid of cytoplasmic IF proteins
